Published in Health Business Week, September 2nd, 2005
The company ended the second quarter with cash, cash equivalents and short-term investments of $27.3 million.
"Based on the progress made in the first half of the year, we believe that Aphton is in a stronger position in terms of our pipeline, our finances and our operations," commented Patrick Mooney, MD, chairman and CEO of Aphton Corporation. "We have cut our going-forward burn rate by almost 50% this year without sacrificing our priority programs and we are continuing to evaluate further steps that could conserve even more capital as we move...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.